CiRC Biosciences Reviews

Chicago, IL

CiRC Biosciences operates in the biotechnology industry, focusing on the development of potential cell therapy treatments. The company is currently in the pre-clinical development stage for a treatment for retinitis pigmentosa (RP) and dry age-related macular degeneration. These conditions are related to vision loss, and CiRC Biosciences is working on innovative solutions to address them. The company is a portfolio company of Paragon Biosciences.